Yvonne Kreith from the group of Prof. Markus Galanski has received a grant of the Hochschuljubiläumsstiftung of the City of Vienna for her project Platinum(IV) complexes coupled to GCPQ for tumour targeting. The novel anticancer agents will be developed in cooperation with Prof. Ijeoma Uchegbu and Prof. Andreas Schätzlein at the UCL School of Pharmacy in London.
